Greetings!
Our edition of nanotimes is live now at (Flash): http://content.yudu.com/A1so7f/Nanotimes05-2011/
Plain text version live at:
http://content.yudu.com/A1so7f/Nanotimes05-2011/resources/plainText.htm
PDF: http://www.nano-times.com/files/nanotimes_11_05.pdf
From the late 90s to 2004 just the word nanotech was a funding umbrella. Today, the situation has regulated itself. E.g. cleantech plays a major role in the nanotechnology sector now.
Nevertheless, many companies don't want to be pushed in the 'nanotech corner' since the word 'nano' carries rather negative connotations because of the public discussion about toxicity. There is no official definition of nano until now, and that doesn't make things easier.
If you retrospectively look at the technology market over the last 10 years in Europe, US and Asia, it is still too bad that Europe - compared to Asia and the US - has so few nano-/microtech companies that are Global Players and also public companies. Europe has extraordinarily many patents. However, a more product-oriented R&D is still missing.
In contrast to the US, reasons are certainly the still rather weakly developed financing options and the lacking risk tolerance of most investors to invest in projects that take at least 10 years to eventually enter the market. However, there are rays of hope: In this edition we introduce a company called QuantaRed Technologies. The Norwegian oil company Statoil ASA got into business with the Austrian high-tech company.
QuantaRed Technologies is a high-tech spin-off company from the Vienna University of Technology. The QuantaRed Technologies team started their R&D activities with Quantum Cascade Laser (QCL) technology for 12 years in 1999 (!). It was the first company world-wide to discover the technological advantages in the measurement of liquids and the industrial potential of this technology.
Another success story is the German Magforce Nanotechnologies (MF6.FSE) that thanks to their long-term thinking investors successfully push their product commercialization. Founder of the German company was Dr Andreas Jordan. He was responsible for about 15 international patent families, and developed the so called NanoTherm® therapy, a new approach for the local treatment of solid tumours. But most importantly for the success, he appointed a CEO for the operational business. Andreas Jordan kept his CSO position, the new CEO concentrated on the market entry.
It doesn't matter at all whether it is nano or micro or cleantech. If there is a market for a new development, if the funding and management work, then the company will continue to be successful and will be able to grow.
If we can be of any further assistance, please don't hesitate to contact us.
Our edition of nanotimes is live now at (Flash): http://content.yudu.com/A1so7f/Nanotimes05-2011/
Plain text version live at:
http://content.yudu.com/A1so7f/Nanotimes05-2011/resources/plainText.htm
PDF: http://www.nano-times.com/files/nanotimes_11_05.pdf
|
Comments